Copyright & Social Media
Communications Law
Settlement of Patent Case With Potential to Limit Reach of Ozempic
I find the use of intellectual properties to limit access to pharmaceutical drugs extremely interesting, particularly in face of international agreements such as the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Recently, pharmaceutical companies Mylan Pharmaceuticals and Novo Nordisk settled a patent dispute over Ozempic, the popular weight loss drug […]